Scientists test 'Goldilocks' doses for blood cancers
NCT ID NCT07474961
Summary
This study aims to find the best medication doses for adults with blood cancers like multiple myeloma and Waldenstrom macroglobulinemia. Researchers will test whether lower doses can work as well as standard doses while causing fewer side effects. The trial will include 400 participants across multiple hospitals and will adapt over time to test different treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital
Aalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aarhus University Hospital
Aarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Copenhagen University Hospital - Rigshospitalet
Copenhagen, Greater Copenhagen Area, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Odense University Hospital
Odense, 5000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Roskilde University Hospital
Roskilde, 4000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.